Global Biopharma Buffer Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biopharma Buffer Market Insights, Forecast to 2034

A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
Global Biopharma Buffer market is expected to reach to US$ 874 million in 2024, with a positive growth of %, compared with US$ 841 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biopharma Buffer industry is evaluated to reach US$ 1068.2 million in 2029. The CAGR will be 3.4% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Biopharma Buffer market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Biopharma Buffer market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report

By Company

Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
Segment by Type
Phosphates Type
Acetates Type
TRIS Type
Others

Segment by Application

Research Institution
Pharmaceutical Industry
Others

Segment by Region

US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline

Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Biopharma Buffer plant distribution, commercial date of Biopharma Buffer, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Biopharma Buffer introduction, etc. Biopharma Buffer Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Biopharma Buffer
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Biopharma Buffer Product Introduction
1.2 Market by Type
1.2.1 Global Biopharma Buffer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Phosphates Type
1.2.3 Acetates Type
1.2.4 TRIS Type
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biopharma Buffer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Research Institution
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biopharma Buffer Sales Estimates and Forecasts 2018-2029
2.2 Global Biopharma Buffer Revenue by Region
2.2.1 Global Biopharma Buffer Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Biopharma Buffer Revenue by Region (2018-2024)
2.2.3 Global Biopharma Buffer Revenue by Region (2024-2029)
2.2.4 Global Biopharma Buffer Revenue Market Share by Region (2018-2029)
2.3 Global Biopharma Buffer Sales Estimates and Forecasts 2018-2029
2.4 Global Biopharma Buffer Sales by Region
2.4.1 Global Biopharma Buffer Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Biopharma Buffer Sales by Region (2018-2024)
2.4.3 Global Biopharma Buffer Sales by Region (2024-2029)
2.4.4 Global Biopharma Buffer Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Biopharma Buffer Sales by Manufacturers
3.1.1 Global Biopharma Buffer Sales by Manufacturers (2018-2024)
3.1.2 Global Biopharma Buffer Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biopharma Buffer in 2022
3.2 Global Biopharma Buffer Revenue by Manufacturers
3.2.1 Global Biopharma Buffer Revenue by Manufacturers (2018-2024)
3.2.2 Global Biopharma Buffer Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Biopharma Buffer Revenue in 2022
3.3 Global Key Players of Biopharma Buffer, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Biopharma Buffer Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Biopharma Buffer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Biopharma Buffer, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Biopharma Buffer, Product Offered and Application
3.8 Global Key Manufacturers of Biopharma Buffer, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biopharma Buffer Sales by Type
4.1.1 Global Biopharma Buffer Historical Sales by Type (2018-2024)
4.1.2 Global Biopharma Buffer Forecasted Sales by Type (2024-2029)
4.1.3 Global Biopharma Buffer Sales Market Share by Type (2018-2029)
4.2 Global Biopharma Buffer Revenue by Type
4.2.1 Global Biopharma Buffer Historical Revenue by Type (2018-2024)
4.2.2 Global Biopharma Buffer Forecasted Revenue by Type (2024-2029)
4.2.3 Global Biopharma Buffer Revenue Market Share by Type (2018-2029)
4.3 Global Biopharma Buffer Price by Type
4.3.1 Global Biopharma Buffer Price by Type (2018-2024)
4.3.2 Global Biopharma Buffer Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Biopharma Buffer Sales by Application
5.1.1 Global Biopharma Buffer Historical Sales by Application (2018-2024)
5.1.2 Global Biopharma Buffer Forecasted Sales by Application (2024-2029)
5.1.3 Global Biopharma Buffer Sales Market Share by Application (2018-2029)
5.2 Global Biopharma Buffer Revenue by Application
5.2.1 Global Biopharma Buffer Historical Revenue by Application (2018-2024)
5.2.2 Global Biopharma Buffer Forecasted Revenue by Application (2024-2029)
5.2.3 Global Biopharma Buffer Revenue Market Share by Application (2018-2029)
5.3 Global Biopharma Buffer Price by Application
5.3.1 Global Biopharma Buffer Price by Application (2018-2024)
5.3.2 Global Biopharma Buffer Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Biopharma Buffer Market Size by Type
6.1.1 US & Canada Biopharma Buffer Sales by Type (2018-2029)
6.1.2 US & Canada Biopharma Buffer Revenue by Type (2018-2029)
6.2 US & Canada Biopharma Buffer Market Size by Application
6.2.1 US & Canada Biopharma Buffer Sales by Application (2018-2029)
6.2.2 US & Canada Biopharma Buffer Revenue by Application (2018-2029)
6.3 US & Canada Biopharma Buffer Market Size by Country
6.3.1 US & Canada Biopharma Buffer Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Biopharma Buffer Sales by Country (2018-2029)
6.3.3 US & Canada Biopharma Buffer Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Biopharma Buffer Market Size by Type
7.1.1 Europe Biopharma Buffer Sales by Type (2018-2029)
7.1.2 Europe Biopharma Buffer Revenue by Type (2018-2029)
7.2 Europe Biopharma Buffer Market Size by Application
7.2.1 Europe Biopharma Buffer Sales by Application (2018-2029)
7.2.2 Europe Biopharma Buffer Revenue by Application (2018-2029)
7.3 Europe Biopharma Buffer Market Size by Country
7.3.1 Europe Biopharma Buffer Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Biopharma Buffer Sales by Country (2018-2029)
7.3.3 Europe Biopharma Buffer Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Biopharma Buffer Market Size
8.1.1 China Biopharma Buffer Sales (2018-2029)
8.1.2 China Biopharma Buffer Revenue (2018-2029)
8.2 China Biopharma Buffer Market Size by Application
8.2.1 China Biopharma Buffer Sales by Application (2018-2029)
8.2.2 China Biopharma Buffer Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biopharma Buffer Market Size by Type
9.1.1 Asia Biopharma Buffer Sales by Type (2018-2029)
9.1.2 Asia Biopharma Buffer Revenue by Type (2018-2029)
9.2 Asia Biopharma Buffer Market Size by Application
9.2.1 Asia Biopharma Buffer Sales by Application (2018-2029)
9.2.2 Asia Biopharma Buffer Revenue by Application (2018-2029)
9.3 Asia Biopharma Buffer Sales by Region
9.3.1 Asia Biopharma Buffer Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Biopharma Buffer Revenue by Region (2018-2029)
9.3.3 Asia Biopharma Buffer Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Biopharma Buffer Market Size by Type
10.1.1 Middle East, Africa and Latin America Biopharma Buffer Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Biopharma Buffer Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Biopharma Buffer Market Size by Application
10.2.1 Middle East, Africa and Latin America Biopharma Buffer Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Biopharma Buffer Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Biopharma Buffer Sales by Country
10.3.1 Middle East, Africa and Latin America Biopharma Buffer Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Biopharma Buffer Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Biopharma Buffer Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Avantor
11.1.1 Avantor Company Information
11.1.2 Avantor Overview
11.1.3 Avantor Biopharma Buffer Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Avantor Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Avantor Recent Developments
11.2 Alfa Aesar (Thermo Fisher)
11.2.1 Alfa Aesar (Thermo Fisher) Company Information
11.2.2 Alfa Aesar (Thermo Fisher) Overview
11.2.3 Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Alfa Aesar (Thermo Fisher) Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Alfa Aesar (Thermo Fisher) Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Biopharma Buffer Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Merck Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Lonza
11.4.1 Lonza Company Information
11.4.2 Lonza Overview
11.4.3 Lonza Biopharma Buffer Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Lonza Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lonza Recent Developments
11.5 Bio-Rad
11.5.1 Bio-Rad Company Information
11.5.2 Bio-Rad Overview
11.5.3 Bio-Rad Biopharma Buffer Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Bio-Rad Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bio-Rad Recent Developments
11.6 BD
11.6.1 BD Company Information
11.6.2 BD Overview
11.6.3 BD Biopharma Buffer Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 BD Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BD Recent Developments
11.7 GE Healthcare
11.7.1 GE Healthcare Company Information
11.7.2 GE Healthcare Overview
11.7.3 GE Healthcare Biopharma Buffer Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 GE Healthcare Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GE Healthcare Recent Developments
11.8 Promega Corporation
11.8.1 Promega Corporation Company Information
11.8.2 Promega Corporation Overview
11.8.3 Promega Corporation Biopharma Buffer Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Promega Corporation Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Promega Corporation Recent Developments
11.9 Hamilton Company
11.9.1 Hamilton Company Company Information
11.9.2 Hamilton Company Overview
11.9.3 Hamilton Company Biopharma Buffer Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Hamilton Company Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hamilton Company Recent Developments
11.10 XZL BIO-TECHNOLOGY
11.10.1 XZL BIO-TECHNOLOGY Company Information
11.10.2 XZL BIO-TECHNOLOGY Overview
11.10.3 XZL BIO-TECHNOLOGY Biopharma Buffer Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 XZL BIO-TECHNOLOGY Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 XZL BIO-TECHNOLOGY Recent Developments
11.11 SRL
11.11.1 SRL Company Information
11.11.2 SRL Overview
11.11.3 SRL Biopharma Buffer Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 SRL Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 SRL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biopharma Buffer Industry Chain Analysis
12.2 Biopharma Buffer Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biopharma Buffer Production Mode & Process
12.4 Biopharma Buffer Sales and Marketing
12.4.1 Biopharma Buffer Sales Channels
12.4.2 Biopharma Buffer Distributors
12.5 Biopharma Buffer Customers
13 Market Dynamics
13.1 Biopharma Buffer Industry Trends
13.2 Biopharma Buffer Market Drivers
13.3 Biopharma Buffer Market Challenges
13.4 Biopharma Buffer Market Restraints
14 Key Findings in The Global Biopharma Buffer Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Biopharma Buffer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Phosphates Type
Table 3. Major Manufacturers of Acetates Type
Table 4. Major Manufacturers of TRIS Type
Table 5. Major Manufacturers of Others
Table 6. Global Biopharma Buffer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Biopharma Buffer Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Biopharma Buffer Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Biopharma Buffer Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Biopharma Buffer Revenue Market Share by Region (2018-2024)
Table 11. Global Biopharma Buffer Revenue Market Share by Region (2024-2029)
Table 12. Global Biopharma Buffer Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Biopharma Buffer Sales by Region (2018-2024) & (KL)
Table 14. Global Biopharma Buffer Sales by Region (2024-2029) & (KL)
Table 15. Global Biopharma Buffer Sales Market Share by Region (2018-2024)
Table 16. Global Biopharma Buffer Sales Market Share by Region (2024-2029)
Table 17. Global Biopharma Buffer Sales by Manufacturers (2018-2024) & (KL)
Table 18. Global Biopharma Buffer Sales Share by Manufacturers (2018-2024)
Table 19. Global Biopharma Buffer Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Biopharma Buffer Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Biopharma Buffer, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Biopharma Buffer Price by Manufacturers 2018-2024 (US$/L)
Table 23. Global Biopharma Buffer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Biopharma Buffer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma Buffer as of 2022)
Table 25. Global Key Manufacturers of Biopharma Buffer, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Biopharma Buffer, Product Offered and Application
Table 27. Global Key Manufacturers of Biopharma Buffer, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Biopharma Buffer Sales by Type (2018-2024) & (KL)
Table 30. Global Biopharma Buffer Sales by Type (2024-2029) & (KL)
Table 31. Global Biopharma Buffer Sales Share by Type (2018-2024)
Table 32. Global Biopharma Buffer Sales Share by Type (2024-2029)
Table 33. Global Biopharma Buffer Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Biopharma Buffer Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Biopharma Buffer Revenue Share by Type (2018-2024)
Table 36. Global Biopharma Buffer Revenue Share by Type (2024-2029)
Table 37. Biopharma Buffer Price by Type (2018-2024) & (US$/L)
Table 38. Global Biopharma Buffer Price Forecast by Type (2024-2029) & (US$/L)
Table 39. Global Biopharma Buffer Sales by Application (2018-2024) & (KL)
Table 40. Global Biopharma Buffer Sales by Application (2024-2029) & (KL)
Table 41. Global Biopharma Buffer Sales Share by Application (2018-2024)
Table 42. Global Biopharma Buffer Sales Share by Application (2024-2029)
Table 43. Global Biopharma Buffer Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Biopharma Buffer Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Biopharma Buffer Revenue Share by Application (2018-2024)
Table 46. Global Biopharma Buffer Revenue Share by Application (2024-2029)
Table 47. Biopharma Buffer Price by Application (2018-2024) & (US$/L)
Table 48. Global Biopharma Buffer Price Forecast by Application (2024-2029) & (US$/L)
Table 49. US & Canada Biopharma Buffer Sales by Type (2018-2024) & (KL)
Table 50. US & Canada Biopharma Buffer Sales by Type (2024-2029) & (KL)
Table 51. US & Canada Biopharma Buffer Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Biopharma Buffer Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Biopharma Buffer Sales by Application (2018-2024) & (KL)
Table 54. US & Canada Biopharma Buffer Sales by Application (2024-2029) & (KL)
Table 55. US & Canada Biopharma Buffer Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Biopharma Buffer Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Biopharma Buffer Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Biopharma Buffer Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Biopharma Buffer Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Biopharma Buffer Sales by Country (2018-2024) & (KL)
Table 61. US & Canada Biopharma Buffer Sales by Country (2024-2029) & (KL)
Table 62. Europe Biopharma Buffer Sales by Type (2018-2024) & (KL)
Table 63. Europe Biopharma Buffer Sales by Type (2024-2029) & (KL)
Table 64. Europe Biopharma Buffer Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Biopharma Buffer Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Biopharma Buffer Sales by Application (2018-2024) & (KL)
Table 67. Europe Biopharma Buffer Sales by Application (2024-2029) & (KL)
Table 68. Europe Biopharma Buffer Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Biopharma Buffer Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Biopharma Buffer Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Biopharma Buffer Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Biopharma Buffer Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Biopharma Buffer Sales by Country (2018-2024) & (KL)
Table 74. Europe Biopharma Buffer Sales by Country (2024-2029) & (KL)
Table 75. China Biopharma Buffer Sales by Type (2018-2024) & (KL)
Table 76. China Biopharma Buffer Sales by Type (2024-2029) & (KL)
Table 77. China Biopharma Buffer Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Biopharma Buffer Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Biopharma Buffer Sales by Application (2018-2024) & (KL)
Table 80. China Biopharma Buffer Sales by Application (2024-2029) & (KL)
Table 81. China Biopharma Buffer Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Biopharma Buffer Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Biopharma Buffer Sales by Type (2018-2024) & (KL)
Table 84. Asia Biopharma Buffer Sales by Type (2024-2029) & (KL)
Table 85. Asia Biopharma Buffer Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Biopharma Buffer Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Biopharma Buffer Sales by Application (2018-2024) & (KL)
Table 88. Asia Biopharma Buffer Sales by Application (2024-2029) & (KL)
Table 89. Asia Biopharma Buffer Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Biopharma Buffer Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Biopharma Buffer Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Biopharma Buffer Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Biopharma Buffer Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Biopharma Buffer Sales by Region (2018-2024) & (KL)
Table 95. Asia Biopharma Buffer Sales by Region (2024-2029) & (KL)
Table 96. Middle East, Africa and Latin America Biopharma Buffer Sales by Type (2018-2024) & (KL)
Table 97. Middle East, Africa and Latin America Biopharma Buffer Sales by Type (2024-2029) & (KL)
Table 98. Middle East, Africa and Latin America Biopharma Buffer Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Biopharma Buffer Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Biopharma Buffer Sales by Application (2018-2024) & (KL)
Table 101. Middle East, Africa and Latin America Biopharma Buffer Sales by Application (2024-2029) & (KL)
Table 102. Middle East, Africa and Latin America Biopharma Buffer Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Biopharma Buffer Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Biopharma Buffer Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Biopharma Buffer Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Biopharma Buffer Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Biopharma Buffer Sales by Country (2018-2024) & (KL)
Table 108. Middle East, Africa and Latin America Biopharma Buffer Sales by Country (2024-2029) & (KL)
Table 109. Avantor Company Information
Table 110. Avantor Description and Major Businesses
Table 111. Avantor Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 112. Avantor Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Avantor Recent Developments
Table 114. Alfa Aesar (Thermo Fisher) Company Information
Table 115. Alfa Aesar (Thermo Fisher) Description and Major Businesses
Table 116. Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 117. Alfa Aesar (Thermo Fisher) Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Alfa Aesar (Thermo Fisher) Recent Developments
Table 119. Merck Company Information
Table 120. Merck Description and Major Businesses
Table 121. Merck Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 122. Merck Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Merck Recent Developments
Table 124. Lonza Company Information
Table 125. Lonza Description and Major Businesses
Table 126. Lonza Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 127. Lonza Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Lonza Recent Developments
Table 129. Bio-Rad Company Information
Table 130. Bio-Rad Description and Major Businesses
Table 131. Bio-Rad Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 132. Bio-Rad Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Bio-Rad Recent Developments
Table 134. BD Company Information
Table 135. BD Description and Major Businesses
Table 136. BD Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 137. BD Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. BD Recent Developments
Table 139. GE Healthcare Company Information
Table 140. GE Healthcare Description and Major Businesses
Table 141. GE Healthcare Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 142. GE Healthcare Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. GE Healthcare Recent Developments
Table 144. Promega Corporation Company Information
Table 145. Promega Corporation Description and Major Businesses
Table 146. Promega Corporation Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 147. Promega Corporation Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Promega Corporation Recent Developments
Table 149. Hamilton Company Company Information
Table 150. Hamilton Company Description and Major Businesses
Table 151. Hamilton Company Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 152. Hamilton Company Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Hamilton Company Recent Developments
Table 154. XZL BIO-TECHNOLOGY Company Information
Table 155. XZL BIO-TECHNOLOGY Description and Major Businesses
Table 156. XZL BIO-TECHNOLOGY Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 157. XZL BIO-TECHNOLOGY Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. XZL BIO-TECHNOLOGY Recent Developments
Table 159. SRL Company Information
Table 160. SRL Description and Major Businesses
Table 161. SRL Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 162. SRL Biopharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. SRL Recent Developments
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Biopharma Buffer Distributors List
Table 167. Biopharma Buffer Customers List
Table 168. Biopharma Buffer Market Trends
Table 169. Biopharma Buffer Market Drivers
Table 170. Biopharma Buffer Market Challenges
Table 171. Biopharma Buffer Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Biopharma Buffer Product Picture
Figure 2. Global Biopharma Buffer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Biopharma Buffer Market Share by Type in 2022 & 2029
Figure 4. Phosphates Type Product Picture
Figure 5. Acetates Type Product Picture
Figure 6. TRIS Type Product Picture
Figure 7. Others Product Picture
Figure 8. Global Biopharma Buffer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Biopharma Buffer Market Share by Application in 2022 & 2029
Figure 10. Research Institution
Figure 11. Pharmaceutical Industry
Figure 12. Others
Figure 13. Biopharma Buffer Report Years Considered
Figure 14. Global Biopharma Buffer Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Biopharma Buffer Revenue 2018-2029 (US$ Million)
Figure 16. Global Biopharma Buffer Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Biopharma Buffer Revenue Market Share by Region (2018-2029)
Figure 18. Global Biopharma Buffer Sales 2018-2029 ((KL)
Figure 19. Global Biopharma Buffer Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Biopharma Buffer Sales YoY (2018-2029) & (KL)
Figure 21. US & Canada Biopharma Buffer Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Biopharma Buffer Sales YoY (2018-2029) & (KL)
Figure 23. Europe Biopharma Buffer Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Biopharma Buffer Sales YoY (2018-2029) & (KL)
Figure 25. China Biopharma Buffer Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Biopharma Buffer Sales YoY (2018-2029) & (KL)
Figure 27. Asia (excluding China) Biopharma Buffer Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Biopharma Buffer Sales YoY (2018-2029) & (KL)
Figure 29. Middle East, Africa and Latin America Biopharma Buffer Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Biopharma Buffer Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Biopharma Buffer in the World: Market Share by Biopharma Buffer Revenue in 2022
Figure 32. Global Biopharma Buffer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Biopharma Buffer Sales Market Share by Type (2018-2029)
Figure 34. Global Biopharma Buffer Revenue Market Share by Type (2018-2029)
Figure 35. Global Biopharma Buffer Sales Market Share by Application (2018-2029)
Figure 36. Global Biopharma Buffer Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Biopharma Buffer Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Biopharma Buffer Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Biopharma Buffer Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Biopharma Buffer Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Biopharma Buffer Revenue Share by Country (2018-2029)
Figure 42. US & Canada Biopharma Buffer Sales Share by Country (2018-2029)
Figure 43. U.S. Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Biopharma Buffer Sales Market Share by Type (2018-2029)
Figure 46. Europe Biopharma Buffer Revenue Market Share by Type (2018-2029)
Figure 47. Europe Biopharma Buffer Sales Market Share by Application (2018-2029)
Figure 48. Europe Biopharma Buffer Revenue Market Share by Application (2018-2029)
Figure 49. Europe Biopharma Buffer Revenue Share by Country (2018-2029)
Figure 50. Europe Biopharma Buffer Sales Share by Country (2018-2029)
Figure 51. Germany Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 52. France Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 56. China Biopharma Buffer Sales Market Share by Type (2018-2029)
Figure 57. China Biopharma Buffer Revenue Market Share by Type (2018-2029)
Figure 58. China Biopharma Buffer Sales Market Share by Application (2018-2029)
Figure 59. China Biopharma Buffer Revenue Market Share by Application (2018-2029)
Figure 60. Asia Biopharma Buffer Sales Market Share by Type (2018-2029)
Figure 61. Asia Biopharma Buffer Revenue Market Share by Type (2018-2029)
Figure 62. Asia Biopharma Buffer Sales Market Share by Application (2018-2029)
Figure 63. Asia Biopharma Buffer Revenue Market Share by Application (2018-2029)
Figure 64. Asia Biopharma Buffer Revenue Share by Region (2018-2029)
Figure 65. Asia Biopharma Buffer Sales Share by Region (2018-2029)
Figure 66. Japan Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 70. India Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Biopharma Buffer Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Biopharma Buffer Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Biopharma Buffer Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Biopharma Buffer Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Biopharma Buffer Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Biopharma Buffer Sales Share by Country (2018-2029)
Figure 77. Brazil Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Biopharma Buffer Revenue (2018-2029) & (US$ Million)
Figure 82. Biopharma Buffer Value Chain
Figure 83. Biopharma Buffer Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Global Biopharma Buffer Market Insights, Forecast to 2034

Global Biopharma Buffer Market Insights, Forecast to 2034

By Company

Segment by Application

Segment by Region

Chapter Outline

Table of Content

List of Figure

Select User License

$4200 Single Licence

$6000 Enterprise Licence

$9100 Corporate Licence

Note : All prices in USD

FAQ'S

User License?

Delivery Time?

How do I place an order?

What is the Payment Options?

Is there a discount for multiple purchases?

Mode of Report Delivery?

Top Industries